Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513465 | SCV000609424 | uncertain significance | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000701008 | SCV000829788 | uncertain significance | X-linked Emery-Dreifuss muscular dystrophy | 2021-08-30 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with methionine at codon 134 of the EMD protein (p.Val134Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with EMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 444835). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000513465 | SCV001987602 | uncertain significance | not provided | 2019-07-16 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function |
Revvity Omics, |
RCV003492086 | SCV003833443 | uncertain significance | Emery-Dreifuss muscular dystrophy 1, X-linked | 2019-05-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271614 | SCV001452890 | uncertain significance | Emery-Dreifuss muscular dystrophy | 2020-09-16 | no assertion criteria provided | clinical testing |